Clinical Trial

Clinical Effectiveness of a Motivational Interviewing-Based Conversational Mobile Application for High-Risk Drinkers

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate and compare the degree of alcohol reduction between high-risk drinkers who use a motivational interviewing-based conversational agent (chatbot) application for four weeks and those in the control group who do not use the application, in order to verify its clinical effectiveness.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-16; most recent amendment 2026-05-11.
Trial Details
NCT Number NCT07238998
Lead Sponsor Yonsei University
Collaborators: BlueSignum Corporation
Conditions Alcohol Drinking, High-Risk Drinking Patterns
Enrollment 220 participants
Start Date 2025-12-19
Primary Completion 2026-11 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-13